A bill for an act relating to the right to try Act.

SF 56 clarifies Iowa's "Right to Try" law to allow patients with terminal or severely debilitating illnesses to access experimental treatments not yet approved by the FDA. It directly affects patients who have exhausted all FDA-approved treatment options and meet specific criteria, including physician recommendations and written informed consent. Key provisions define "eligible patient," require documentation of exhausted treatments, mandate detailed consent disclosures about risks (including potential hastened death), and clarify that health insurers aren't obligated to cover these treatments. The bill does not change FDA approval processes but creates a framework for patient access under strict conditions.